PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment
2026-08-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCARâ„¢ T-Cell
2026-08-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Completes Landmark Global Health Pilot Advancing Women's and Infant Health
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Reports Strong Profitable Growth in H1 2026
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Fosun Pharma Announces 2026 Interim Results
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innovent Announces 2026 Interim Results and Business Updates
2026-08-25T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved